Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

4 terminated/withdrawn out of 32 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

13%

4 trials in Phase 3/4

Results Transparency

0 of 24 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

22(75.9%)

Phase 3

3(10.3%)

Phase 2

3(10.3%)

Phase 4

1(3.4%)

29Total

N/A(22)

Phase 3(3)

Phase 2(3)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (32)

Showing 20 of 32 trials

NCT06896045Not ApplicableSuspended

Multicenter Study Evaluating the Relationship Between Perceived Daily Stress Level and Glycemic Level in Subjects With Type 1 Diabetes

Role: lead

NCT06985862Not ApplicableSuspended

Development of Artificial Intelligence Tools for the Detection of Stress Markers and Consideration of Stress States in the Monitoring of Subjects With Type 1 Diabetes

Role: lead

NCT05567692Active Not Recruiting

Subjects With T2D or at Risk of T2D Cohort Follow-up

Role: lead

NCT06598865Not ApplicableRecruiting

Comparative Effectiveness of Prescribed Adapted Physical Activity (APA), Either Practiced Independently After Training, or Supervised by an APA Teacher, on Glycemic Regulation in People With Unbalanced Type 2 Diabetes.

Role: lead

NCT04725591Not ApplicableCompleted

Diabeloop for Teens

Role: lead

NCT06365255Completed

National Epidemiological Study of the Possible Impact of Stress on Glycaemic Control in Patients With Type 1 Diabetes

Role: lead

NCT04537520Not ApplicableCompleted

Interventional Clinical Trial Comparing Kerecis Omega3 Wound Versus SOC in Diabetic Foot Wounds

Role: lead

NCT04257370Not ApplicableCompleted

Kerecis Omega3 Wound Plus SOC vs. SOC Alone in Treating Severe Diabetic Foot Ulcers and Forefoot Amputations

Role: collaborator

NCT01727349Not ApplicableCompleted

Validation of a Predictive Risk Equation for Type 2 Diabetes in Families With Risk

Role: lead

NCT04042207Not ApplicableCompleted

Diabeloop for Highly Unstable Type 1 Diabetes

Role: lead

NCT04190277Not ApplicableTerminated

Safety Assessment of DBLUS System in Adolescent and Adult Patients With Type 1 Diabetes and Assessment of Its Clinical Efficacy (DIABELOOP SP8)

Role: lead

NCT02521675Not ApplicableCompleted

Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity in Real Life Conditions

Role: lead

NCT02986256Not ApplicableCompleted

Evaluation of the Management of Diabetic Foot Ulcers by Telemedicine on the Number of Hospital Days in Diabetic Patients

Role: lead

NCT03671915Not ApplicableCompleted

Diabeloop for Kids

Role: lead

NCT02987556Not ApplicableCompleted

Diabeloop WP7 : Crossover Evaluation of the Safety and the Efficacy of Artificial Pancreas Diabeloop (WP7)

Role: lead

NCT02287532Not ApplicableCompleted

Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen

Role: lead

NCT02627911Phase 2Completed

Diabeloop WP6.2 : Crossover Evaluation of Glycemic Control

Role: lead

NCT00934336Not ApplicableCompleted

Importance in Type 1 Diabetes Patients of an Optimized Control of Post-Prandial Glycaemia on Oxidant Stress Prevention

Role: lead

NCT01530789Terminated

Paramedical Consultation in Telemedicine

Role: lead

NCT02101229Phase 2Completed

Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital

Role: lead